Martin Hornberger

Title: Martin Hornberger: Innovator in Indoleamine 2,3-Dioxygenase Modulation

Introduction

Martin Hornberger is a notable inventor based in Ladenburg, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of modulators for indoleamine 2,3-dioxygenase (IDO1). His work focuses on addressing IDO1-mediated diseases, which are critical in various therapeutic areas.

Latest Patents

Hornberger holds a patent for "Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase." This invention provides novel compounds that serve as modulators of IDO1, offering potential therapeutic benefits in the prophylaxis and treatment of diseases associated with this enzyme. The patent details compounds according to a specific formula, including their enantiomers, diastereomers, tautomers, or pharmaceutically acceptable salts.

Career Highlights

Throughout his career, Martin Hornberger has been associated with Phenex Discovery Verwaltungs-GmbH, where he has contributed to various research initiatives. His expertise in medicinal chemistry has positioned him as a key figure in the development of innovative therapeutic solutions.

Collaborations

Hornberger has collaborated with notable colleagues, including Christoph Steeneck and Olaf Kinzel. These partnerships have enhanced the research and development efforts within his field, fostering innovation and progress.

Conclusion

Martin Hornberger's work in the modulation of indoleamine 2,3-dioxygenase represents a significant advancement in the treatment of IDO1-mediated diseases. His contributions to medicinal chemistry and collaboration with esteemed colleagues underscore his impact in the field.